DESCRIPTION
A woman aged 67 years with a history of multiple myeloma who was receiving chemotherapy was admitted to the medical intensive care unit with massive gastrointestinal bleeding. She denied having any family history of bleeding diathesis. Her laboratory studies showed a normal platelet count and coagulation profile, whereas her serum-free lambda light chain level was elevated at 183.25 mg/dL (reference: 0.57-2.63).
She underwent gastric endoscopy that showed a distal gastric body mass of 3×7 cm on the greater curvature with an adjacent collection of submucosal hematoma (figure 1). Biopsy samples were obtained from the mass that showed an abnormally thickened blood vessel with amyloid-like material in the wall (figure 2). The patient had also had a colon biopsy 5 years earlier, which showed amorphous Congo red-positive deposits in the vessel walls.
Two days following repeated bouts of haematemesis and retching, she developed right periorbital, atraumatic, non-blanching ecchymosis. No further skin bruises were observed (figure 3).
The bleeding manifestations frequently observed in patients with immunoglobulin light-chain amyloidosis have been attributed to different pathogenic factors, including amyloid deposits in capillary walls, factor X deficiency and the presence of plasma components interfering with fibrin formation. However, bleeding in most patients occurs in the absence of abnormal clotting test results, suggesting that haemorrhage in amyloidosis is most often due to amyloid infiltration of blood vessels. 1 Skin bleeding in these patients is called amyloid purpura. Classically, it occurs in the periorbital region either spontaneously or after strenuous coughing or vomiting. 2 
Learning points
▸ Amyloidosis may cause vascular fragility and therefore increases bleeding tendency. ▸ Periorbital cutaneous bleeding in these patients is called amyloid purpura. 
